Clinical Development
Adaptive vs Fixed Trial Design: Evaluating the Trade-Offs
A clinical trial can be statistically elegant and still be difficult for patients to live through. A fixed design gives the study…
Just in
Medical Affairs
Advisory Board Failures: A Medical Affairs Case Study
Sixty percent. That figure represents the proportion of total session time consumed by company slide presentations in a typical…
Pharmacovigilance
Pharmacovigilance System Master File Architecture
A Pharmacovigilance System Master File (PSMF) is not a static compliance dossier assembled for an inspection. It is the…
Pharmacovigilance
EudraVigilance Signal Detection: What MAHs Must Know
On 22 July 2025, Implementing Regulation (EU) 2025/1466 entered into force and brought the EudraVigilance signal detection pilot…
Medical Consulting
Fractional CMO Strategy: Actionable Steps for Biotechs
Organizations deploying fractional executive structures report leadership overhead cost reductions of 40% to 60% compared to…
Medical Affairs
Investigator-Initiated Studies: Internal Pharma Review
We have all seen it happen. A brilliant investigator approaches us at a medical conference, eyes bright with a research idea that…
Regulatory Compliance
Promotional Review Pitfalls: A PMCPA Case Study
The two-signature certification process is often presented as the last line of defence between compliant promotion and regulatory…
Clinical Development
Surrogate Endpoints vs Overall Survival: Protocol Strategy
Nearly three-quarters of randomized oncology trials that hit their primary surrogate endpoint never demonstrate an overall…
News
About
Elevating clinical practice and patient care.